National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Cybin is a biotechnology business based in the US. Cybin stocks (CLXPF.US) are listed on the OTCQB and all prices are listed in US Dollars. Its last market close was $2.07 – the same closing value as a week prior. Cybin employs 38 staff and has a trailing 12-month revenue of around $864,000.
National Bank Direct Brokerage
CIBC Investor's Edge
|Latest market close||$2.14|
|52-week range||$0.00 - $0.00|
|50-day moving average||$2.58|
|200-day moving average||$1.75|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.26|
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $2.14 from 2021-10-06
|1 week (2023-05-21)||N/A|
|1 month (2023-04-27)||N/A|
|3 months (2023-02-25)||N/A|
|6 months (2022-11-27)||N/A|
|1 year (2022-05-28)||N/A|
|2 years (2021-06-01)||49.96%|
|3 years (2020-06-01)||2,640.08%|
|5 years (2018-05-28)||N/A|
|Gross profit TTM||$-311,000|
|Return on assets TTM||-41.35%|
|Return on equity TTM||-73.59%|
|Market capitalisation||$475.5 million|
TTM: trailing 12 months
We're not expecting Cybin to pay a dividend over the next 12 months.
Cybin's shares were split on a 1:6 basis on 10 November 2020. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cybin shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Cybin shares which in turn could have impacted Cybin's share price.
Over the last 12 months, Cybin's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while Cybin's is -1.0407. This would suggest that Cybin's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Cybin has bucked the trend.
Cybin Inc. , a biotechnology company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Cybin U. S. , and Natures Journey. The Serenity Life and Cybin U. S.
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
The best stock trading app for beginners is easy to use and offers free trades.Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
Compare some of the best bad credit loans in PEI.
Your guide to the features, interest rates and fees to expect when you apply for a short-term loan with Credito.
Pay for unexpected bills and avoid overdrafts when you sign up for apps like Bree.
Take a closer look at the debt relief solutions, features and fees of Debt Relief Canada.
Learn more about Desjardins Online Brokerage (Disnat) to see if it’s the right broker for you.
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
Compare apps like Nyble in Canada to access emergency funding.
Your guide to buying and financing a car in Canada with RightRide.
Your guide to bad credit car loans in BC and how to find the right financing for your needs.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.